BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35172563)

  • 1. Outstanding outcomes in infants with
    Guest EM; Kairalla JA; Hilden JM; Dreyer ZE; Carroll AJ; Heerema NA; Wang CY; Devidas M; Gore L; Salzer WL; Winick NJ; Carroll WL; Raetz EA; Borowitz M; Loh ML; Hunger SP; Brown PA
    Haematologica; 2022 May; 107(5):1205-1208. PubMed ID: 35172563
    [No Abstract]   [Full Text] [Related]  

  • 2. FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.
    Brown PA; Kairalla JA; Hilden JM; Dreyer ZE; Carroll AJ; Heerema NA; Wang C; Devidas M; Gore L; Salzer WL; Winick NJ; Carroll WL; Raetz EA; Borowitz MJ; Small D; Loh ML; Hunger SP
    Leukemia; 2021 May; 35(5):1279-1290. PubMed ID: 33623141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
    Pieters R; De Lorenzo P; Ancliffe P; Aversa LA; Brethon B; Biondi A; Campbell M; Escherich G; Ferster A; Gardner RA; Kotecha RS; Lausen B; Li CK; Locatelli F; Attarbaschi A; Peters C; Rubnitz JE; Silverman LB; Stary J; Szczepanski T; Vora A; Schrappe M; Valsecchi MG
    J Clin Oncol; 2019 Sep; 37(25):2246-2256. PubMed ID: 31283407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.
    Tomizawa D; Miyamura T; Imamura T; Watanabe T; Moriya Saito A; Ogawa A; Takahashi Y; Hirayama M; Taki T; Deguchi T; Hori T; Sanada M; Ohmori S; Haba M; Iguchi A; Arakawa Y; Koga Y; Manabe A; Horibe K; Ishii E; Koh K
    Blood; 2020 Oct; 136(16):1813-1823. PubMed ID: 32845001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postchemotherapy immune status in infants with acute lymphoblastic leukemia: A report from the JPLSG MLL-10 trial.
    Arakawa Y; Hasegawa D; Miyamura T; Ohshima J; Kimura S; Imamura T; Koga Y; Yamamoto S; Ogawa A; Shinoda K; Eguchi M; Hosoi H; Imai K; Koh K; Tomizawa D
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29772. PubMed ID: 35796397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.
    Fechina L; Popov A; Tsaur G; Henze G; Shorikov E; Makarova O; Khlebnikova O; Zhukova Y; Arakaev O; Streneva O; Verzhbitskaya T; Riger T; Solodovnikov A; Lapotentova E; Aleinikova O; Myakova N; Boichenko E; Kondratchik K; Nikonova O; Shapochnik A; Goroshkova M; Ponomareva N; Novichkova G; Karachunskiy A; Roumiantsev A
    Leukemia; 2023 Nov; 37(11):2276-2281. PubMed ID: 37741948
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Robinson BW; Kairalla JA; Devidas M; Carroll AJ; Harvey RC; Heerema NA; Willman CL; Ball AR; Woods EC; Ballantyne NC; Urtishak KA; Behm FG; Reaman GH; Hilden JM; Camitta BM; Winick NJ; Pullen J; Carroll WL; Hunger SP; Dreyer ZE; Felix CA
    Haematologica; 2023 Oct; 108(10):2865-2871. PubMed ID: 36861410
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
    Faulk KE; Kairalla JA; Dreyer ZE; Carroll AJ; Heerema NA; Devidas M; Carroll WL; Raetz EA; Loh ML; Hunger SP; Borowitz M; Wang C; Guest E; Brown PA
    Pediatr Blood Cancer; 2023 May; ():e30467. PubMed ID: 37259259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution and optimization of therapies for acute lymphoblastic leukemia in infants.
    Tomizawa D
    Int J Hematol; 2023 Feb; 117(2):162-172. PubMed ID: 36441356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid lineage switch in
    Bataller A; Abuasab T; McCall D; Wang W; Cuglievan B; Issa GC; Jabbour E; Short N; DiNardo CD; Tang G; Garcia-Manero G; Kantarjian HM; Sasaki K
    Haematologica; 2024 Jan; 109(1):293-297. PubMed ID: 37646654
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment strategy for infant acute lymphoblastic leukemia].
    Miyamura T
    Rinsho Ketsueki; 2022; 63(7):791-798. PubMed ID: 35922950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report.
    Permikin Z; Popov A; Verzhbitskaya T; Riger T; Plekhanova O; Makarova O; Froňková E; Trka J; Meyer C; Marschalek R; Tsaur G; Fechina L
    Leuk Res; 2022 Jan; 112():106758. PubMed ID: 34864370
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.
    De Lorenzo P; Moorman AV; Pieters R; Dreyer ZE; Heerema NA; Carroll AJ; Hunger SP; Harvey R; Willman CL; Devidas M; Valsecchi MG; Harrison CJ
    Leukemia; 2014 Feb; 28(2):428-30. PubMed ID: 24072099
    [No Abstract]   [Full Text] [Related]  

  • 14. Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.
    Loftus JP; Yahiaoui A; Brown PA; Niswander LM; Bagashev A; Wang M; Schauf A; Tannheimer S; Tasian SK
    Haematologica; 2021 Apr; 106(4):1067-1078. PubMed ID: 32414848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
    Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia in infants: A quarter century of nationwide efforts in Japan.
    Tomizawa D; Miyamura T; Koh K; Ishii E
    Pediatr Int; 2022 Jan; 64(1):e14935. PubMed ID: 34324764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.
    Dreyer ZE; Dinndorf PA; Camitta B; Sather H; La MK; Devidas M; Hilden JM; Heerema NA; Sanders JE; McGlennen R; Willman CL; Carroll AJ; Behm F; Smith FO; Woods WG; Godder K; Reaman GH
    J Clin Oncol; 2011 Jan; 29(2):214-22. PubMed ID: 21135279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-induced Deletion in 11q23 Leading to Fusion of
    Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
    Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia.
    Kamens JL; Nance S; Koss C; Xu B; Cotton A; Lam JW; Garfinkle EAR; Nallagatla P; Smith AMR; Mitchell S; Ma J; Currier D; Wright WC; Kavdia K; Pagala VR; Kim W; Wallace LM; Cho JH; Fan Y; Seth A; Twarog N; Choi JK; Obeng EA; Hatley ME; Metzger ML; Inaba H; Jeha S; Rubnitz JE; Peng J; Chen T; Shelat AA; Guy RK; Gruber TA
    Nat Commun; 2023 Feb; 14(1):809. PubMed ID: 36781850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.